Filing Details
- Accession Number:
- 0000937556-18-000125
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-06 17:52:31
- Reporting Period:
- 2018-08-02
- Accepted Time:
- 2018-08-06 17:52:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
937556 | Masimo Corp | MASI | Electromedical & Electrotherapeutic Apparatus (3845) | 330368882 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1228621 | E Joe Kiani | C/O Masimo Corporation 52 Discovery Irvine CA 92618 | Ceo And Chairman Of The Board | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-08-02 | 29,273 | $23.98 | 168,514 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-08-02 | 29,273 | $109.08 | 139,241 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2018-08-06 | 30,801 | $23.98 | 170,042 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-08-06 | 30,801 | $109.03 | 139,241 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (Right to Buy) | Disposition | 2018-08-02 | 29,273 | $23.98 | 29,273 | $23.98 |
Common Stock | Non-Qualified Stock Option (Right to Buy) | Disposition | 2018-08-06 | 30,801 | $23.98 | 30,801 | $23.98 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
270,727 | 2010-01-11 | 2019-01-11 | No | 4 | M | Direct |
239,926 | 2010-01-11 | 2019-01-11 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 229,290 | Indirect | By Trust |
Common Stock | 550,000 | Indirect | By Trust |
Common Stock | 352,919 | Indirect | By Trust |
Common Stock | 359,000 | Indirect | By Trust |
Common Stock | 2,250,291 | Indirect | By Trust |
Common Stock | 10,373 | Indirect | See Footnote |
Common Stock | 9,000 | Indirect | See Footnote |
Footnotes
- The shares covered by this Form 4 were exercised and sold pursuant to a Rule 10b5-1 Sales Plan dated as of August 14, 2017, which is intended to comply with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.
- The price reported in Column 4 represents the weighted average sales price per share. The actual sales prices ranged from a low of $109.00 per share to a high of $109.35 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The price reported in Column 4 represents the weighted average sales price per share. The actual sales prices ranged from a low of $109.00 per share to a high of $109.20 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Shares held in four trusts for which Mr. Kiani is not the trustee.
- Shares held in one trust for which Mr. Kiani is the sole trustee.
- Shares held in Masimo Retirement Savings Plan.
- Shares held by an immediate family member for which Mr. Kiani exercises voting and investment control.
- This option was granted on January 11, 2009 and is exercisable as the option vests. This option vested over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.